Type 2 diabetes mellitus and bone
暂无分享,去创建一个
[1] M. Frost,et al. Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease. , 2015, European journal of endocrinology.
[2] P. Ungprasert,et al. Sodium‐glucose cotransporter 2 (SGLT2) inhibitors and fracture risk in patients with type 2 diabetes mellitus: A meta‐analysis , 2017, Diabetes/metabolism research and reviews.
[3] Chung-Yi Li,et al. Increased Risks of Hip Fracture in Diabetic Patients of Taiwan , 2008, Diabetes Care.
[4] R. Nuti,et al. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. , 2012, The Journal of clinical endocrinology and metabolism.
[5] J. Kanis,et al. FRAX underestimates fracture risk in patients with diabetes , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] T. Svensson,et al. Obesity in orthopedic patients. , 2009, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[7] S. Derksen,et al. Biphasic fracture risk in diabetes: a population-based study. , 2007, Bone.
[8] A. Hofman,et al. Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study. , 1996, Bone.
[9] S. Mori,et al. Risk factors associated with falls in elderly patients with type 2 diabetes. , 2015, Journal of diabetes and its complications.
[10] C. Coleman,et al. Impact of Diabetes Mellitus on Bone Health , 2019, International journal of molecular sciences.
[11] W. Tan,et al. A United Kingdom perspective on the relationship between body mass index (BMI) and bone health: a cross sectional analysis of data from the Nottingham Fracture Liaison Service. , 2014, Bone.
[12] A. Alshaikh,et al. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. , 2013, Bone.
[13] Yu Gu,et al. Are falls prevention programs effective at reducing the risk factors for falls in people with type-2 diabetes mellitus and peripheral neuropathy: A systematic review with narrative synthesis. , 2017, Journal of diabetes and its complications.
[14] H. Choi,et al. Trabecular bone score as an indicator for skeletal deterioration in diabetes. , 2015, The Journal of clinical endocrinology and metabolism.
[15] M. Lorentzon,et al. A High Amount of Local Adipose Tissue Is Associated With High Cortical Porosity and Low Bone Material Strength in Older Women , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] L. Kuller,et al. Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes , 2009, Diabetes Care.
[17] P. Vestergaard,et al. Biochemical bone turnover markers in diabetes mellitus - A systematic review. , 2016, Bone.
[18] Luigi Ferrucci,et al. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. , 2014, The lancet. Diabetes & endocrinology.
[19] W. Leslie,et al. DXA-Based Measurements in Diabetes: Can They Predict Fracture Risk? , 2017, Calcified Tissue International.
[20] I. Idris,et al. DPP-4 inhibitor therapy and bone fractures in people with Type 2 diabetes - A systematic review and meta-analysis. , 2016, Diabetes research and clinical practice.
[21] H. Leufkens,et al. Long‐term use of dipeptidyl peptidase‐4 inhibitors and risk of fracture: A retrospective population‐based cohort study , 2017, Diabetes, obesity & metabolism.
[22] C. Browning,et al. Exercise interventions for the improvement of falls-related outcomes among older adults with diabetes mellitus: A systematic review and meta-analyses. , 2017, Journal of diabetes and its complications.
[23] M. Monami,et al. Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures , 2011, Diabetes Care.
[24] Jennifer M. Harris,et al. Teriparatide in patients with osteoporosis and type 2 diabetes. , 2016, Bone.
[25] J. Pérez-Castrillón,et al. Type 2 Diabetes Mellitus as a Risk Factor for Hip Fracture , 2004, Journal of the American Geriatrics Society.
[26] Ahmed H. YoussefAgha,et al. Attenuated PTH responsiveness to vitamin D deficiency among patients with type 2 diabetes and chronic hyperglycemia. , 2017, Diabetes research and clinical practice.
[27] T. Keaveny,et al. Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. , 2005, Bone.
[28] V. Beral,et al. Body mass index and physical activity in relation to the incidence of hip fracture in postmenopausal women , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[29] M. Rubin,et al. Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes. , 2016, The Journal of clinical endocrinology and metabolism.
[30] A. LaCroix,et al. Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). , 2012, Bone.
[31] B. Carleton,et al. Thiazolidinediones and fractures in men and women. , 2009, Archives of internal medicine.
[32] E. Eriksen,et al. Reduced Bone Material Strength is Associated with Increased Risk and Severity of Osteoporotic Fractures. An Impact Microindentation Study , 2017, Calcified Tissue International.
[33] S. Cremers,et al. Bone structure and turnover in type 2 diabetes mellitus , 2012, Osteoporosis International.
[34] J. Cauley,et al. Adipokines and the risk of fracture in older adults , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[35] S. Satterfield,et al. Insulin Resistance Is Associated With Decreased Quadriceps Muscle Strength in Nondiabetic Adults Aged ≥70 Years , 2009, Diabetes Care.
[36] I. Reid,et al. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. , 2006, Bone.
[37] S. Cummings,et al. Older women with diabetes have an increased risk of fracture: a prospective study. , 2001, The Journal of clinical endocrinology and metabolism.
[38] A. Díez-Pérez,et al. The association between fracture and obesity is site‐dependent: A population‐based study in postmenopausal women , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] P. Vestergaard,et al. Are Antiresorptive Drugs Effective Against Fractures in Patients with Diabetes? , 2011, Calcified Tissue International.
[40] A. Tiran,et al. Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. , 2006, The Journal of clinical endocrinology and metabolism.
[41] J. A. Garcia-Salcedo,et al. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. , 2012, The Journal of clinical endocrinology and metabolism.
[42] Yangang Wang,et al. Increased risk of vertebral fracture in patients with diabetes: a meta-analysis of cohort studies , 2016, International Orthopaedics.
[43] S. Mittelman,et al. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. , 2009, The Journal of clinical endocrinology and metabolism.
[44] A. LaCroix,et al. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2014): Oral Communication Abstracts , 2014, Osteoporosis International.
[45] Robert R. Henry,et al. Type 2 diabetes mellitus , 2015, Nature Reviews Disease Primers.
[46] Y. Lang,et al. Diabetes mellitus and risk of hip fractures: a meta-analysis , 2015, Osteoporosis International.
[47] J. Kanis,et al. Longer Duration of Diabetes Strongly Impacts Fracture Risk Assessment: The Manitoba BMD Cohort , 2016, The Journal of clinical endocrinology and metabolism.
[48] S. Cummings,et al. Risk factors for nonvertebral fracture in obese older women. , 2011, The Journal of clinical endocrinology and metabolism.
[49] Qiang Zhang,et al. Diabetes mellitus and risk of falls in older adults: a systematic review and meta-analysis. , 2016, Age and ageing.
[50] E. Friedman,et al. Advanced glycosylation end products in patients with diabetic nephropathy. , 1991, The New England journal of medicine.
[51] J. Cauley,et al. Effects of Raloxifene on Fracture Risk in Postmenopausal Women: The Raloxifene Use for The Heart Trial , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[52] S. Kirkland,et al. Associations Among Disease Conditions, Bone Mineral Density, and Prevalent Vertebral Deformities in Men and Women 50 Years of Age and Older: Cross‐Sectional Results From the Canadian Multicentre Osteoporosis Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[53] S. Zhai,et al. Lack of evidence for a harmful effect of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta‐analysis of randomized controlled trials , 2016, Diabetes, obesity & metabolism.
[54] M. Bouxsein,et al. A bone structural basis for fracture risk in diabetes. , 2008, The Journal of clinical endocrinology and metabolism.
[55] A. Hofman,et al. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. , 2005, Osteoporosis International.
[56] C. Qualls,et al. Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone‐active hormones , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[57] L. Forsén,et al. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey , 1999, Diabetologia.
[58] A. LaCroix,et al. Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[59] R. Scragg,et al. Vitamin D and Type 2 Diabetes , 2009 .
[60] G. Hawker,et al. The Risk of Hip Fractures in Older Individuals With Diabetes , 2007, Diabetes Care.
[61] A. Folsom,et al. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. , 2001, Diabetes care.
[62] P. Vestergaard,et al. Use of glucose-lowering drugs and risk of fracture in patients with type 2 diabetes. , 2017, Bone.
[63] A. Cerami,et al. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.
[64] C. Earthman,et al. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications , 2012, International Journal of Obesity.
[65] M. Bouxsein,et al. Defects in cortical microarchitecture among African-American women with type 2 diabetes , 2015, Osteoporosis International.
[66] D. Carpenter,et al. Association between ankle fractures and obesity. , 2012, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.
[67] Thomas Baum,et al. Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[68] P. Vestergaard,et al. The use of incretins and fractures – a meta‐analysis on population‐based real life data , 2017, British journal of clinical pharmacology.
[69] S. Gnudi,et al. Relationship of body mass index with main limb fragility fractures in postmenopausal women , 2009, Journal of Bone and Mineral Metabolism.
[70] L. Jacob,et al. Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany—A retrospective analysis of real-world data , 2017, Osteoporosis International.
[71] P. Gamache,et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study , 2016, British Medical Journal.
[72] M. E. Leite Duarte,et al. [Histomorphometric analysis of the bone tissue in patients with non-insulin-dependent diabetes (DMNID)]. , 1996, Revista do Hospital das Clinicas.
[73] R. Cumming,et al. Diabetes and risk of fracture: The Blue Mountains Eye Study. , 2001, Diabetes care.
[74] S. Papapoulos,et al. Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site , 2017, Osteoporosis International.
[75] Manna Zhang,et al. Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists’ treatment: a meta-analysis of randomized controlled trials , 2015, Endocrine.
[76] M. Bredella,et al. Vertebral Bone Marrow Fat Is Positively Associated With Visceral Fat and Inversely Associated With IGF‐1 in Obese Women , 2011, Obesity.
[77] Walter C Willett,et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. , 2007, American journal of epidemiology.
[78] Toru Yamaguchi,et al. Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells. , 2015, Biochemical and biophysical research communications.
[79] Jianhong Zhu,et al. Dipeptidyl peptidase-4 inhibitors and fracture risk: an updated meta-analysis of randomized clinical trials , 2016, Scientific Reports.
[80] T. Sugimoto,et al. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. , 2012, The Journal of clinical endocrinology and metabolism.
[81] S. Cummings,et al. Pentosidine and increased fracture risk in older adults with type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.
[82] Song Xu,et al. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats , 2011, Journal of cellular biochemistry.
[83] R. Harnish,et al. Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures , 2015, Osteoporosis International.
[84] J. Lehmann,et al. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. , 1996, Molecular pharmacology.
[85] W. Leslie,et al. Trabecular Bone Score , 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.
[86] Avis J. Thomas,et al. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. , 2015, The lancet. Diabetes & endocrinology.
[87] S. Cummings,et al. Endogenous testosterone levels, physical performance, and fall risk in older men. , 2006, Archives of internal medicine.
[88] S. Wild,et al. Contemporary Risk of Hip Fracture in Type 1 and Type 2 Diabetes: A National Registry Study From Scotland† , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[89] C. Cooper,et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study , 2012, BMJ : British Medical Journal.
[90] T. Sugimoto,et al. Advanced Glycation End Products, Diabetes, and Bone Strength , 2016, Current Osteoporosis Reports.
[91] Jian-Min Yuan,et al. Diabetes and Risk of Hip Fracture in the Singapore Chinese Health Study , 2010, Diabetes Care.
[92] J. Cauley,et al. Bone Mass and Strength in Older Men With Type 2 Diabetes: The Osteoporotic Fractures in Men Study , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[93] Jasmine A. Nirody,et al. Cortical bone laminar analysis reveals increased midcortical and periosteal porosity in type 2 diabetic postmenopausal women with history of fragility fractures compared to fracture-free diabetics , 2016, Osteoporosis International.
[94] D. Rao,et al. Bone Loss and Bone Turnover in Diabetes , 1995, Diabetes.
[95] Stephanie Boutroy,et al. Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 2: Trabecular Bone Score. , 2015, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[96] P. J. Bowman,et al. Intentional and Unintentional Weight Loss Increase Bone Loss and Hip Fracture Risk in Older Women , 2003, Journal of the American Geriatrics Society.
[97] Julie Flahive,et al. Obesity is not protective against fracture in postmenopausal women: GLOW. , 2011, The American journal of medicine.
[98] K. Jáuregui-Renaud,et al. Influence of the body mass index on the occurrence of falls in patients with type 2 diabetes mellitus. , 2015, Obesity research & clinical practice.
[99] L. Kuller,et al. Accelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes , 2007, Diabetes Care.
[100] R. Jorde,et al. Smoking and other determinants of bone turnover , 2019, PloS one.
[101] D. Kohan,et al. Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control , 2013, Kidney international.
[102] C. Poiană,et al. OSTEOPOROSIS AND FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. , 2019, Acta endocrinologica.
[103] P. Vestergaard,et al. MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. , 2017, European journal of endocrinology.
[104] Hang Lee,et al. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. , 2010, The Journal of clinical endocrinology and metabolism.
[105] L. Lix,et al. Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture? , 2014, Osteoporosis International.
[106] P. Vestergaard,et al. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis , 2007, Osteoporosis International.
[107] H. Kroger,et al. Body mass index as a predictor of fracture risk: A meta-analysis , 2005, Osteoporosis International.
[108] T. Sugimoto,et al. Diabetic Patients Have an Increased Risk of Vertebral Fractures Independent of BMD or Diabetic Complications , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[109] D. Mellström,et al. Type 2 Diabetes Mellitus Is Associated With Better Bone Microarchitecture But Lower Bone Material Strength and Poorer Physical Function in Elderly Women: A Population‐Based Study , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[110] Karen C Johnson,et al. Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. , 2006, The Journal of clinical endocrinology and metabolism.
[111] C. Furberg,et al. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis , 2009, Canadian Medical Association Journal.
[112] J. Pasco,et al. Bone mineral density in diabetes and impaired fasting glucose , 2019, Osteoporosis International.
[113] K. Jepsen,et al. Biomechanical Mechanisms: Resolving the Apparent Conundrum of Why Individuals With Type II Diabetes Show Increased Fracture Incidence Despite Having Normal BMD , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[114] Ta-Liang Chen,et al. Increased Risk of Fracture and Postfracture Adverse Events in Patients With Diabetes: Two Nationwide Population-Based Retrospective Cohort Studies , 2014, Diabetes Care.
[115] K. Lapane,et al. Sulfonylureas and Risk of Falls and Fractures: A Systematic Review , 2013, Drugs & Aging.
[116] Elizabeth Selvin,et al. Association of Diabetes, Comorbidities, and A1C With Functional Disability in Older Adults , 2010, Diabetes Care.
[117] Gabriëlle H S Buitendijk,et al. High Bone Mineral Density and Fracture Risk in Type 2 Diabetes as Skeletal Complications of Inadequate Glucose Control , 2013, Diabetes Care.
[118] Karin Kraft,et al. [Type-2 diabetes]. , 2010, MMW Fortschritte der Medizin.
[119] Chih-Cheng Hsu,et al. Fracture Risk After Bariatric Surgery: A 12-Year Nationwide Cohort Study , 2015, Medicine.
[120] M. Michalak,et al. Type 2 diabetes and risk of low-energy fractures in postmenopausal women: meta-analysis of observational studies , 2016, Aging Clinical and Experimental Research.
[121] Deepak Vashishth,et al. Heterogeneous Glycation of Cancellous Bone and Its Association with Bone Quality and Fragility , 2012, PloS one.
[122] S. Perkins,et al. Vitamin D and hyperparathyroidism in obesity. , 2011, The Journal of clinical endocrinology and metabolism.
[123] D. Chappard,et al. Use of glucagon‐like peptide‐1 receptor agonists and bone fractures: A meta‐analysis of randomized clinical trials (胰高血糖素样肽‐1受体激动剂的使用与骨折的关系:一项对随机临床试验的meta分析) , 2014, Journal of diabetes.
[124] Richard Barnett,et al. Diabetes mellitus. , 1993, The Medical journal of Australia.
[125] S. Majumdar,et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. , 2010, Journal of Clinical Endocrinology and Metabolism.
[126] J. Kelsey,et al. Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial. , 2004, Diabetes care.
[127] C. Torp-Pedersen,et al. Hip and distal arm fracture rates in peri‐ and postmenopausal insulin‐treated diabetic females , 1994, Journal of internal medicine.
[128] E. Yu,et al. Fracture Risk After Bariatric Surgery: Roux‐en‐Y Gastric Bypass Versus Adjustable Gastric Banding , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[129] A. Díez-Pérez,et al. Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[130] O. Johnell,et al. Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women , 2006, Osteoporosis International.
[131] N. Watts,et al. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. , 2016, The Journal of clinical endocrinology and metabolism.
[132] M. Ruffing-Rahal,et al. Older Women , 1987, Ageing & Society.
[133] A. Apanovitch,et al. Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events , 2014, Drug Safety.
[134] D. Kiel,et al. Diabetes and Deficits in Cortical Bone Density, Microarchitecture, and Bone Size: Framingham HR‐pQCT Study , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[135] P. Vestergaard,et al. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk , 2005, Diabetologia.
[136] Bess Dawson-Hughes,et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.
[137] Chao Wan,et al. Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition , 2010, Cell.
[138] Deepak L. Bhatt,et al. Two‐year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy , 2015, Obesity.
[139] T. Therneau,et al. Fracture Risk in Type 2 Diabetes: Update of a Population‐Based Study , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[140] S. Yano,et al. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. , 2008, The Journal of clinical endocrinology and metabolism.
[141] A. Breggia,et al. Determinants of bone mineral density in obese premenopausal women. , 2011, Bone.
[142] S. Cummings,et al. Risk Factors for Nonvertebral Fracture in Obese Older Women , 2011 .
[143] H. Kuo,et al. Inverse association between insulin resistance and gait speed in nondiabetic older men: results from the U.S. National Health and Nutrition Examination Survey (NHANES) 1999-2002 , 2009, BMC geriatrics.
[144] D. Cibula,et al. Bone quality assessment in type 2 diabetes mellitus , 2014, Osteoporosis International.
[145] S. Costantini,et al. Bone health in diabetes and prediabetes , 2019, World journal of diabetes.
[146] J. Cauley,et al. Postmenopausal weight change and incidence of fracture: post hoc findings from Women’s Health Initiative Observational Study and Clinical Trials , 2015, BMJ : British Medical Journal.
[147] S. Cremers,et al. Circulating osteogenic precursor cells in type 2 diabetes mellitus. , 2012, The Journal of clinical endocrinology and metabolism.
[148] M. Amraei,et al. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis , 2017, Therapeutics and clinical risk management.
[149] E. Vittinghoff,et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. , 2011, JAMA.
[150] S. Bandinelli,et al. Role of Muscle Mass and Muscle Quality in the Association Between Diabetes and Gait Speed , 2012, Diabetes Care.
[151] K. Lapane,et al. Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus. , 2015, Diabetes research and clinical practice.
[152] W. Leslie,et al. TBS (trabecular bone score) and diabetes-related fracture risk. , 2013, The Journal of clinical endocrinology and metabolism.
[153] P. Lips,et al. MANAGEMENT OF ENDOCRINE DISEASE: The effect of vitamin D supplementation on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. , 2017, European journal of endocrinology.
[154] S. Khosla,et al. In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 Diabetes , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.